Apple launches Goldman Sachs-linked credit card – the Apple Card

By Nikita Chaurasia  Date: 2019-03-26

Apple launches Goldman Sachs-linked credit card – the Apple Card

The American technology giant Apple Inc. has reportedly unveiled its new no-fee credit card, hailed as the Apple Card, which it has developed in partnership with Goldman Sachs and Master Card. The new credit card is pivoting on the tech giant’s mobile payment & digital wallet service, Apple Pay, that has made inroads in the area of merchant acceptance.

Sources claimed that the new card can be used as an alternative payment option in place of Apple Pay. The card is a sleek, minimalist titanium card, which only has the user’s name printed on it with lasers and no other personal information. Sources added that users can conveniently sign up through their iPhones and gain access to the card in no time, after it is available across the United States this summer.

Jennifer Bailey, an Apple executive, revealed that the Apple Card pays around 2 percent cashback on Apple Pay transactions, 1 percent on purchases using the physical card and about 3 percent on direct Apple purchases. She added that the rewards will be ready to be availed on an everyday basis.

According to a report, Apple Card’s wallet screen will be containing all the necessary user information, including the current balance. It will further allow users to make payments, keep a check on their spending and seek real-time information regarding transactions. The report further mentions that Apple has made sure that every transaction is secure and confidential, with a card number for each device which is stored in iPhone’s Secure Element. However, each transaction is safeguarded with a one-time security code that is generated following authentication by means of a touch ID or face ID. 

The invention of the new card is a step ahead into a new territory for both Apple and Goldman Sachs. The first credit card by Goldman Sachs is an innovative drive into consumer financial products after its long-term services to various institutional investors, corporations as well as governments.

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

By Nikita Chaurasia

Motorola Solutions has announced to have been selected by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to offer the Norwegian Health Emergency Service with a new CRS (Command Central Control Room Solution). Confirming the news,&...

Nestle India exploring options to directly sell products to consumers

Nestle India exploring options to directly sell products to consumers

By Nikita Chaurasia

Nestle India Ltd. is reportedly exploring their options of trying their hands at direct selling since consumers are largely turning towards the internet to purchase products ranging from staples to medicines amidst the COVID-19 pandemic. While the n...

Razorpay: New funding en route, meteoric rise in market value expected

Razorpay: New funding en route, meteoric rise in market value expected

By Nikita Chaurasia

Indian startup Razorpay is reportedly in discussions with Singapore-based sovereign wealth fund GIC Pvt. Ltd. and other existing investors to raise around USD 200 million in a funding round that would allow the fintech company to double its valuation...

FDA to allow pharma companies modify COVID-19 shots amid variants surge

FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the dise...

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

By Nikita Chaurasia

China-based leading pharmaceutical organization Gan & Lee Pharmaceuticals Co. Ltd. has announced to have signed a strategic collaboration with the International Diabetes Federation (IDF) to bolster its efforts towards promoting the prevention and...